Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Walsh

Showing results (201-210 of 361) with videos related to

Pageof 37
Sort By:
The Journal of Urology|September 8, 2005
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomyStephen J Freedland, Leslie A Mangold, Patrick C Walsh, et al.
The Journal of Urology|August 19, 2017
Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?Wesley W Ludwig, Zhaoyong Feng, Bruce J Trock, et al.
BJU International|March 6, 2010
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenariansPhillip M Pierorazio, Elizabeth Humphreys, Patrick C Walsh, et al.
Urology|July 3, 2003
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003Masood A Khan, Misop Han, Alan W Partin, et al.
The Prostate|September 2, 2003
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinomaJun Luo, Thomas A Dunn, Charles M Ewing, et al.
Urology|June 8, 2012
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomyDeborah R Kaye, Patrick C Walsh, George J Netto, et al.
The Journal of Urology|May 21, 2010
Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomyStacy Loeb, Danil V Makarov, Edward M Schaeffer, et al.
The Journal of Urology|November 16, 2004
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancerMohamad E Allaf, Ganesh S Palapattu, Bruce J Trock, et al.
The Journal of Urology|November 19, 2013
Re: detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study: I. Y. Kim, P. K. Modi, E. Sadimin, Y.-S. Ha, J. H. Kim, D. Skarecky, D. Y. Cha, C. O. Wambi, Y.-C. Ou, B. Yuh, S. Park, E. Llukani, D. M. Albala, T. Wilson, T. Ahlering, K. Badani, H. Ahn, D. I. Lee, M. May, W.-J. Kim and d. H. Lee J Urol 2013;190:527-534Mark W Ball, Jeffrey K Mullins, Jonathan I Epstein, et al.
Urology|September 8, 2004
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progressionHakan Aydin, Toyonori Tsuzuki, David Hernandez, et al.
Pageof 37

Showing results (201-210 of 361) with videos related to

Sort By:
Pageof 37
The Journal of Urology|September 8, 2005
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomyStephen J Freedland, Leslie A Mangold, Patrick C Walsh, et al.
The Journal of Urology|August 19, 2017
Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?Wesley W Ludwig, Zhaoyong Feng, Bruce J Trock, et al.
BJU International|March 6, 2010
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenariansPhillip M Pierorazio, Elizabeth Humphreys, Patrick C Walsh, et al.
Urology|July 3, 2003
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003Masood A Khan, Misop Han, Alan W Partin, et al.
The Prostate|September 2, 2003
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinomaJun Luo, Thomas A Dunn, Charles M Ewing, et al.
Urology|June 8, 2012
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomyDeborah R Kaye, Patrick C Walsh, George J Netto, et al.
The Journal of Urology|May 21, 2010
Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomyStacy Loeb, Danil V Makarov, Edward M Schaeffer, et al.
The Journal of Urology|November 16, 2004
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancerMohamad E Allaf, Ganesh S Palapattu, Bruce J Trock, et al.
The Journal of Urology|November 19, 2013
Re: detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study: I. Y. Kim, P. K. Modi, E. Sadimin, Y.-S. Ha, J. H. Kim, D. Skarecky, D. Y. Cha, C. O. Wambi, Y.-C. Ou, B. Yuh, S. Park, E. Llukani, D. M. Albala, T. Wilson, T. Ahlering, K. Badani, H. Ahn, D. I. Lee, M. May, W.-J. Kim and d. H. Lee J Urol 2013;190:527-534Mark W Ball, Jeffrey K Mullins, Jonathan I Epstein, et al.
Urology|September 8, 2004
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progressionHakan Aydin, Toyonori Tsuzuki, David Hernandez, et al.
Pageof 37